Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 1: design of potent and specific 3,9-diazaspiro[5.5]undecanes

Add time:09/29/2019    Source:infona.pl

The synthesis and biological activity of novel glycoprotein IIb-IIIa antagonists containing the 3,9-diazaspiro[5.5]undecane nucleus are described. The potent activity of these compounds as platelet aggregation inhibitors demonstrates the utility of the spirocyclic structures as a central template for nonpeptide RGD mimics.

We also recommend Trading Suppliers and Manufacturers of 3,9-Diazaspiro[5.5]undecane (cas 180-46-1). Pls Click Website Link as below: cas 180-46-1 suppliers

Prev:Synthesis of substituted 3,9-diazaspiro[5.5]undecanes via spirocyclization of pyridine substrates
Next:Practical and divergent synthesis of 1- and 5-substituted 3,9-diazaspiro[5.5]undecanes and undecan-2-ones)